CURRENT SERIES:
Prostate Cancer
November 26, 2013
December 17, 2013
December 17, 2013
NOW PLAYING
Episode 4 - Treatment Guidelines and Economic Considerations
4 of 13
January 10, 2014
February 19, 2014
February 19, 2014
March 21, 2014
March 21, 2014
April 22, 2014
April 22, 2014
May 20, 2014
May 20, 2014

Episode 4 - Treatment Guidelines and Economic Considerations

During this segment, Raoul S. Concepcion, MD, discusses the rapid development of expensive agents for castration-resistant prostate cancer and explains how treatment costs create a challenge to clinicians and payers. Michael Kolodziej, MD, responds by explaining what variables payers consider when making decisions about treatment coverage.
During this segment, Raoul S. Concepcion, MD, explains how the rapid development of agents for castration-resistant prostate cancer (CRPC) has led to an expanding number of clinical guidelines, developed by multiple organizations, for clinicians’ use during important treatment-decisions.

However, he explains that the treatment options recommended in these guidelines are expensive, creating a challenge to both clinicians and payers.

To clarify misconceptions about medical policy and coverage for patients with CRPC, Michael Kolodziej, MD, discusses the variables that payers consider when making decisions about coverage for these expensive treatment options.



 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up